Skip to main content

1 Result(s)

within Samuel Thomas McMordie Remove this filter

and

  1. Article

    Open Access

    Cost-Effectiveness Analysis of Recombinant Factor VIII Fc-Fusion Protein (rFVIIIFc) for the Treatment of Severe Hemophilia A in Italy Incorporating Real-World Dosing and Joint Health Data

    Patients with severe hemophilia A (SHA) in Italy are routinely treated with standard half-life recombinant factor VIII (rFVIII) products. rFVIII Fc-fusion protein (rFVIIIFc) is an extended half-life rFVIII pro...

    Ash Bullement, Samuel Thomas McMordie, Anthony James Hatswell… in PharmacoEconomics - Open (2020)

    Download PDF (692 KB) View Article